Vanda Pharmaceuticals Receives Japanese Orphan Drug Designation For Imsidolimab In Generalized Pustular Psoriasis
Vanda Pharmaceuticals Inc VNDA
$6.45
▼ -2.86%
($-0.19)
Open
$6.54
Prev Close
$6.64
Day Range
$6.38 – $6.65
52W Range
$4.14 – $9.94
Market Cap
$360.21M
Beta
0.59
EPS (TTM)
$-4.05
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2006-04-12 |
| Shares Out. | 60,140,000 |
| Website | vandapharma.com/ ↗ |
| Phone | 12027343400 |
Vanda Pharmaceuticals Inc is a publicly traded company under the ticker symbol VNDA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
11 analysts (2026-05-01)